Biotech

All Articles

Former Seagen chief executive officer introduces brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer in 2013 for...

Ironwood makes more bid for $1B GI medication along with new subgroup data

.On the heels of a phase 3 win that neglected to excite investors, Ironwood Pharmaceuticals is actua...

Novartis inks $150M offer for autoimmune molecular glue

.Don't stop Monte Rosa Therapeutics right now. The Boston-based biotech is having a ball after signi...

Jade carves out director team with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable management hirings, firings and r...

Septerna goes social with upsized offering of $288M

.Commemorating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fi...

AbbVie brings in Richter richer, paying $25M to make up invention contract

.AbbVie has actually come back to the resource of its own antipsychotic goliath Vraylar searching fo...

GenSight gets in ultimate weeks of cash money path as earnings stream edges out of grasp

.GenSight Biologics is actually weeks far from losing cash. Again. The biotech only possesses adequa...

AZ licenses disposed of rare health condition drug to Monopar Rehabs

.Monopar Rehabs is actually recouping a drug coming from the scrap heap of AstraZeneca's unusual dis...

Arcus' brand-new HIF-2a records in kidney cancer mention potential edge over Merck's Welireg, professionals claim

.Along with brand new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of p...

Roche wagers around $1B to extend Dyno gene therapy shipment deal

.After creating a genetics therapy partnership with Dyno Therapies in 2020, Roche is actually back f...